Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.
about
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesBoosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.Native-like Env trimers as a platform for HIV-1 vaccine design.Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.Approaches to the induction of HIV broadly neutralizing antibodies.Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.Identification and specificity of broadly neutralizing antibodies against HIVHow HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.HIV-1 Cross-reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Non-human Primate.Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies.Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.Advances in HIV-1 Vaccine Development.Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.Structural Insights from HIV-Antibody Coevolution and Related Immunization Studies
P2860
Q33612459-256E5B89-0FFE-4789-BAD1-A91E5467C0ACQ36290038-1CB15B8C-7BAB-4C09-92AC-ACC0E17F7F0FQ36303368-55AD4D22-1106-4BF7-B3CA-D0FC0BED1302Q37252966-A18C1A7F-71E2-4B34-8EC5-37CDA1A68978Q37363517-622BDFD2-6301-488B-A891-DF6EE23FADEDQ37409244-AEBE9A51-ED7E-4BCE-993D-FD766CDC3386Q37633417-9287AA7E-2E74-4897-925B-00861215C32DQ38753943-867AFB2A-A2E0-4E77-B684-C6790D4852D8Q38897259-A8BBB86A-240E-46B8-B2B0-9EAC3C738A29Q38936867-5E3587BA-4C76-4025-A65F-B9D3653E7DDDQ39108760-CD6F70BB-4C6C-44A4-A2BA-1283A73EC62AQ39108796-411FD7EC-411E-4837-854F-53390C92FA51Q39250593-60EA7565-0777-412A-8B79-B31077811E18Q40073016-5A2F7A8B-F814-4D2D-9203-DCE3007B8E25Q40226810-6E4C5009-EEDA-47EC-B4AC-70B0D244B55AQ40449984-30671FA1-2000-4757-A4D0-3AD74FD42364Q40568483-5843582A-BD27-4A77-ACFD-B64FDEC98111Q47215738-893BB575-75B3-4E91-9F3E-17A44270864DQ50043326-E5B44F49-D05E-4601-9559-12D52D5086CBQ52609661-A42724D5-FA57-42E8-A166-305ED9FFA439Q53693698-31BCB5A8-87D0-45DD-ACD1-0C9C102C7F4EQ57093739-2748545F-3A1C-4A77-8DC9-637A106311D7
P2860
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@ast
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@en
type
label
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@ast
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@en
altLabel
Structural Constraints of Vacc ...... ting the Receptor-Binding Site
@en
prefLabel
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@ast
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@en
P2093
P2860
P50
P1433
P1476
Structural Constraints of Vacc ...... ing the Receptor-Binding Site.
@en
P2093
Amanda Eaton
Andrew Foulger
Christina Stolarchuk
Cindy M Bowman
Daniela Fera
Hua-Xin Liao
Kara Anasti
Krissey E Lloyd
Laura L Sutherland
Leila Eslamizar
P2860
P356
10.1016/J.CELREP.2015.12.017
P407
P577
2015-12-22T00:00:00Z